The inhibition of mitochondrial calcium transport by lanthanides and ruthenium red

• Published in: Biochemical journal Vol. 140; no. 2; pp. 143 - 155
• Main Authors: Reed, K C, Bygrave, F L
• Format: Journal Article
• Language: English
• Published: England 01.05.1974
• Subjects: Animals; Binding Sites; Binding, Competitive; Bioenergetics; Biological Transport - drug effects; Calcium - metabolism; Coloring Agents - pharmacology; Electron Transport Complex IV; Europium - pharmacology; Kinetics; Lanthanum - pharmacology; Mitochondria, Liver - metabolism; Neodymium - pharmacology; Oxygen Consumption; Rats; Ruthenium - pharmacology; Spectrophotometry; Terbium - pharmacology
• ISSN: 0264-6021; 0306-3283; 1470-8728
• DOI: 10.1042/bj1400143

An EGTA (ethanedioxybis(ethylamine)tetra-acetic acid)-quench technique was developed for measuring initial rates of (45)Ca(2+) transport by rat liver mitochondria. This method was used in conjunction with studies of Ca(2+)-stimulated respiration to examine the mechanisms of inhibition of Ca(2+) transport by the lanthanides and Ruthenium Red. Ruthenium Red inhibits Ca(2+) transport non-competitively with K(i) 3x10(-8)m; there are 0.08nmol of carrier-specific binding sites/mg of protein. The inhibition by La(3+) is competitive (K(i)=2x10(-8)m); the concentration of lanthanide-sensitive sites is less than 0.001nmol/mg of protein. A further difference between their modes of action is that lanthanide inhibition diminishes with time whereas that by Ruthenium Red does not. Binding studies showed that both classes of inhibitor bind to a relatively large number of external sites (probably identical with the ;low-affinity' Ca(2+)-binding sites). La(3+) competes with Ruthenium Red for most of these sites, but a small fraction of the bound Ruthenium Red (less than 2nmol/mg of protein) is not displaced by La(3+). The results are discussed briefly in relation to possible models for a Ca(2+) carrier.